Advanced search
Publication Cover
Research and Reports in Urology Volume 12, 2020 - Issue
Submit an article Journal homepage
143
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Risk Factors for Prostate Volume Progression After Prostate-Transurethral Resection

Gede Wirya Kusuma Duarsa1 Department of Surgery, Faculty of Medicine, Udayana University, Bali, IndonesiaCorrespondence[email protected]
,
Daniel Oktavianus Dau1 Department of Surgery, Faculty of Medicine, Udayana University, Bali, Indonesia
,
Ida Bagus Putra Pramana1 Department of Surgery, Faculty of Medicine, Udayana University, Bali, IndonesiaORCID Iconhttps://orcid.org/0000-0001-7876-5909
ORCID Icon,
Pande Made Wisnu Tirtayasa1 Department of Surgery, Faculty of Medicine, Udayana University, Bali, Indonesia
,
I Wayan Yudiana1 Department of Surgery, Faculty of Medicine, Udayana University, Bali, Indonesia
,
Kadek Budi Santosa1 Department of Surgery, Faculty of Medicine, Udayana University, Bali, Indonesia
,
Anak Agung Gde Oka1 Department of Surgery, Faculty of Medicine, Udayana University, Bali, IndonesiaORCID Iconhttps://orcid.org/0000-0002-1336-1599
ORCID Icon,
Tjokorda Gde Bagus Mahadewa1 Department of Surgery, Faculty of Medicine, Udayana University, Bali, IndonesiaORCID Iconhttps://orcid.org/0000-0003-1212-2219
ORCID Icon &
Christopher Ryalino2 Department of Anesthesiology, Faculty of Medicine, Udayana University, Bali, Indonesia
 show all
Pages 175-178 | Published online: 05 May 2020

References

  • Patel ND, Parsons JK. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol. 2014. doi:10.4103/0970-1591.126900
  • Lepor H. Evaluating men with benign prostatic hyperplasia. Rev Urol. 2004;6:S8.16985855
  • Taoka R, Kakehi Y. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia. Asian J Urol. 2017;4(3):158–163. doi:10.1016/j.ajur.2017.02.00429264225
  • Oka AAG, Duarsa GWK, Novianti PA, Mahadewa TGB, Ryalino C. The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia. Res Rep Urol. 2019;11:91–96. doi:10.2147/RRU.S18941431114764
  • Giri D, Ittmann M. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. Am J Pathol. 2001;159(1):139–147. doi:10.1016/S0002-9440(10)61681-111438462
  • Duarsa GWK, Oka AAG, Maliawan S, et al. Elevated tumor necrosis factor-α and transforming growth factor-β in prostatic tissue are risk factors for lower urinary tract symptoms after transurethral resection of the prostate in benign prostatic hyperplasia patients with urinary retention. Open Urol Nephrol J. 2018;11(1):46–53. doi:10.2174/1874303x01811010046
  • Zhang SJ, Qian HN, Zhao Y, et al. Relationship between age and prostate size. Asian J Androl. 2013;15(1):116–120. doi:10.1038/aja.2012.12723223031
  • Ngai HY, Yuen KKS, Ng CM, Cheng CH, Chu SKP. Metabolic syndrome and benign prostatic hyperplasia: an update. Asian J Urol. 2017;4(3):164–173. doi:10.1016/j.ajur.2017.05.00129264226
  • Chughtai B, Lee R, Te A, Kaplan S. Role of inflammation in benign prostatic hyperplasia. Rev Urol. 2011;13:147.22110398
  • Parsons JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 2010;5(4):212–218. doi:10.1007/s11884-010-0067-221475707
  • Choi H, Kim JH, Shim JS, et al. Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement. Urol Int. 2014;93(4):425–430. doi:10.1159/00035762625300422
  • Putra IBOW, Hamid ARAH, Mochtar CA, Umbas R. Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia. Prostate Int. 2016;4(2):43–48. doi:10.1016/j.prnil.2016.03.00227358842
  • Deori R, Das B, Rahman MA. A study of relationship of prostate volume, prostate specific antigen and age in benign prostatic hyperplasia. Int J Contemp Med Res. 2017;4(7):1582–1586.
  • Kosaka T, Miyajima A, Oya M. Is DHT production by 5a-reductase friend or foe in prostate cancer? Front Oncol. 2014;4. doi:10.3389/fonc.2014.00247.
  • Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res. 2008;20(S3):S11––S18. doi:10.1038/ijir.2008.55
  • Lee CL, Kuo HC. Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: current concepts. Tzu Chi Med J. 2017. doi:10.4103/tcmj.tcmj_20_17
  • Milonas D, Verikaite J, Jievaltas M. The effect of complete transurethral resection of the prostate on symptoms, quality of life, and voiding function improvement. Cent Eur J Urol. 2015;68(2). doi:10.5173/ceju.2015.507
  • De Nunzio C, Cindolo L, Gacci M, et al. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms. Urology. 2014;84(5):1181–1187. doi:10.1016/j.urology.2014.07.01825443931
  • Kramer G, Marberger M. Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol. 2006. doi:10.1097/01.mou.0000193368.91823.1b
  • Lee C, Jia Z, Rahmatpanah F, et al. Role of the adjacent stroma cells in prostate cancer development and progression: synergy between TGFβ and IGF signaling. Biomed Res Int. 2014;2014:1–8. doi:10.1155/2014/502093

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.